![]() ImaginAb ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins. | ![]() Shanghai Model Organisms Center Shanghai Model Organisms Center (上海南方模式生物科技股份有限公司) is a company that specializes in the research and development, breeding, analysis, and testing of genetically modified animal models. | ||||
Founding Date | Founding Date 2009 | Founding Date 2007 | Founding Date 2011 | Founding Date 2000 | Founding Date 1986 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations San Francisco, US HQ | Locations Inglewood, US HQ Bracknell, GB | Locations BR HQ | Locations CN HQ | Locations Crumlin, GB HQ Freiburg Im Breisgau, DE Cape Town, ZA Edinburgh, GB Porton Down, GB Sittingbourne, GB see more |
Employees | Employees 5 | Employees 195% decrease | Employees N/A | Employees 731 | Employees 3491% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) R$1.2b (FY, 2024) | Revenue (est.) ¥415.6m (FY, 2025) | Revenue (est.) £55.5m (FY, 2020) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods R$174.8m (FY, 2024) | Cost of goods ¥203.4m (FY, 2025) | Cost of goods £25.4m (FY, 2020) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit R$1.1b (FY, 2024) | Gross profit ¥214.9m (FY, 2025) | Gross profit £30.1m (FY, 2020) |
Net income | Net income N/A | Net income N/A | Net income (R$117.2m) (FY, 2024) | Net income ¥31.4m (FY, 2025) | Net income (£9.9m) (FY, 2020) |

ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.
View company
Shanghai Model Organisms Center (上海南方模式生物科技股份有限公司) is a company that specializes in the research and development, breeding, analysis, and testing of genetically modified animal models.
View companyBBI Solutions is a company that develops and manufactures immuno-diagnostics reagents.
View company